Supportive care in patients with cancer during the COVID-19 pandemic

M Aapro; G H Lyman; C Bokemeyer; B L Rapoport; N Mathieson; N Koptelova; P Cornes; R Anderson; P Gascón; N M Kuderer

doi:10.1016/j.esmoop.2020.100038

Supportive care in patients with cancer during the COVID-19 pandemic

Standard

Supportive care in patients with cancer during the COVID-19 pandemic. / Aapro, M; Lyman, G H; Bokemeyer, C; Rapoport, B L; Mathieson, N; Koptelova, N; Cornes, P; Anderson, R; Gascón, P; Kuderer, N M.

In: ESMO OPEN, Vol. 6, No. 1, 02.2021, p. 100038.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Aapro, M, Lyman, GH, Bokemeyer, C, Rapoport, BL, Mathieson, N, Koptelova, N, Cornes, P, Anderson, R, Gascón, P & Kuderer, NM 2021, 'Supportive care in patients with cancer during the COVID-19 pandemic', ESMO OPEN, vol. 6, no. 1, pp. 100038. https://doi.org/10.1016/j.esmoop.2020.100038

APA

Aapro, M., Lyman, G. H., Bokemeyer, C., Rapoport, B. L., Mathieson, N., Koptelova, N., Cornes, P., Anderson, R., Gascón, P., & Kuderer, N. M. (2021). Supportive care in patients with cancer during the COVID-19 pandemic. ESMO OPEN, 6(1), 100038. https://doi.org/10.1016/j.esmoop.2020.100038

Vancouver

Aapro M, Lyman GH, Bokemeyer C, Rapoport BL, Mathieson N, Koptelova N et al. Supportive care in patients with cancer during the COVID-19 pandemic. ESMO OPEN. 2021 Feb;6(1):100038. https://doi.org/10.1016/j.esmoop.2020.100038

Bibtex

@article{5d4b46b9ebcd4e5da11c73bd9deea5cd,

title = "Supportive care in patients with cancer during the COVID-19 pandemic",

abstract = "Cancer care has been profoundly impacted by the global pandemic of severe acute respiratory syndrome coronavirus 2 disease (coronavirus disease 2019, COVID-19), resulting in unprecedented challenges. Supportive care is an essential component of cancer treatment, seeking to prevent and manage chemotherapy complications such as febrile neutropenia, anaemia, thrombocytopenia/bleeding, thromboembolic events and nausea/vomiting, all of which are common causes of hospitalisation. These adverse events are an essential consideration under routine patient management, but particularly so during a pandemic, a setting in which clinicians aim to minimise patients' risk of infection and need for hospital visits. Professional medical oncology societies have been providing updated guidelines to support health care professionals with the management, treatment and supportive care needs of their patients with cancer under the threat of COVID-19. This paper aims to review the recommendations made by the most prominent medical oncology societies for devising and modifying supportive care strategies during the pandemic.",

author = "M Aapro and Lyman, {G H} and C Bokemeyer and Rapoport, {B L} and N Mathieson and N Koptelova and P Cornes and R Anderson and P Gasc{\'o}n and Kuderer, {N M}",

year = "2021",

month = feb,

doi = "10.1016/j.esmoop.2020.100038",

language = "English",

volume = "6",

pages = "100038",

journal = "ESMO OPEN",

issn = "2059-7029",

publisher = "BMJ PUBLISHING GROUP",

number = "1",

}

RIS

TY - JOUR

T1 - Supportive care in patients with cancer during the COVID-19 pandemic

AU - Aapro, M

AU - Lyman, G H

AU - Bokemeyer, C

AU - Rapoport, B L

AU - Mathieson, N

AU - Koptelova, N

AU - Cornes, P

AU - Anderson, R

AU - Gascón, P

AU - Kuderer, N M

PY - 2021/2

Y1 - 2021/2

N2 - Cancer care has been profoundly impacted by the global pandemic of severe acute respiratory syndrome coronavirus 2 disease (coronavirus disease 2019, COVID-19), resulting in unprecedented challenges. Supportive care is an essential component of cancer treatment, seeking to prevent and manage chemotherapy complications such as febrile neutropenia, anaemia, thrombocytopenia/bleeding, thromboembolic events and nausea/vomiting, all of which are common causes of hospitalisation. These adverse events are an essential consideration under routine patient management, but particularly so during a pandemic, a setting in which clinicians aim to minimise patients' risk of infection and need for hospital visits. Professional medical oncology societies have been providing updated guidelines to support health care professionals with the management, treatment and supportive care needs of their patients with cancer under the threat of COVID-19. This paper aims to review the recommendations made by the most prominent medical oncology societies for devising and modifying supportive care strategies during the pandemic.

AB - Cancer care has been profoundly impacted by the global pandemic of severe acute respiratory syndrome coronavirus 2 disease (coronavirus disease 2019, COVID-19), resulting in unprecedented challenges. Supportive care is an essential component of cancer treatment, seeking to prevent and manage chemotherapy complications such as febrile neutropenia, anaemia, thrombocytopenia/bleeding, thromboembolic events and nausea/vomiting, all of which are common causes of hospitalisation. These adverse events are an essential consideration under routine patient management, but particularly so during a pandemic, a setting in which clinicians aim to minimise patients' risk of infection and need for hospital visits. Professional medical oncology societies have been providing updated guidelines to support health care professionals with the management, treatment and supportive care needs of their patients with cancer under the threat of COVID-19. This paper aims to review the recommendations made by the most prominent medical oncology societies for devising and modifying supportive care strategies during the pandemic.

U2 - 10.1016/j.esmoop.2020.100038

DO - 10.1016/j.esmoop.2020.100038

M3 - SCORING: Review article

C2 - 33421735

VL - 6

SP - 100038

JO - ESMO OPEN

JF - ESMO OPEN

SN - 2059-7029

IS - 1

ER -